Search

Your search keyword '"Aibar, J."' showing total 186 results

Search Constraints

Start Over You searched for: Author "Aibar, J." Remove constraint Author: "Aibar, J."
186 results on '"Aibar, J."'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

3. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

6. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

7. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

9. Timing and characteristics of venous thromboembolism after noncancer surgery

10. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

11. The prognostic value of blood cellular indices in pulmonary embolism.

12. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

13. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

16. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

17. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

19. Outcomes of venous thromboembolism in patients with inherited thrombophilia treated with direct oral anticoagulants: insights from the RIETE registry.

20. Evaluation of the clinical-immuno-radiological and legal consequences in the presence of post-surgical gossypiboma

21. Anticoagulation and venous thromboembolism in patients aged 90 years and older: Data from the RIETE registry.

24. Bleeding risk in hospitalized patients with COVID‐19 receiving intermediate‐ or therapeutic doses of thromboprophylaxis

25. Above-soil and in-soil degradation of oxo- and bio-degradable mulches: a qualitative approach

28. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

30. The melatonin contained in beer can provide health benefits, due to its antioxidant, anti-inflammatory and immunomodulatory properties

31. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

32. Prognostic impact of acute kidney injury in patients with acute pulmonary embolism data from the RIETE registry

33. Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial

34. The melatonin contained in beer can provide health benefits, due to its antioxidant, anti-inflammatory and immunomodulatory properties

35. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

36. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

37. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

39. Herpesviruses and coronavirus infection

40. Ventilation/perfusion (V/Q) scanning in contemporary patients with pulmonary embolism: utilization rates and predictors of use in a multinational study

42. Timing and characteristics of venous thromboembolism after noncancer surgery

43. COVID-19 pandemic as a risk factor for the reactivation of herpes viruses

44. COVID-19 pandemic as a risk factor for the reactivation of herpes viruses

45. The Pfizer-BNT162b2 mRNA-based vaccine against SARS-CoV-2 may be responsible for awakening the latency of herpes varicella-zoster virus

47. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

49. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

Catalog

Books, media, physical & digital resources